CBD Retail Trends

  • CBD Retail Trends
  • Industry News
  • Function
    • Anxiety
    • Excercise
    • Focus
    • Immunity
    • Recovery
    • Sleep
    • Stress
  • Products
    • Beverages
    • Delta-8 THC
    • Edibles
    • Oils & Tinctures
    • Oral Supplements & Tinctures
    • Shots
    • Smoking and Vape
    • Snacks
    • Supplements
    • Topicals
  • Retail Segment
    • Convenience
    • Health & Wellness
    • Medical Dispensary
    • Pets
    • Specialty
  • Commentary
  • FAQs
  • Research
  • Legal & Regulatory
  • Video

Alaska Approves Sales of Tauri-Gum

State’s Division of Agriculture approved company’s Product Endorsement request for CBD and CBG chewing gum products, clearing way for distribution and retail sales.

By Thomas Mulloy | December 24, 2021

Diversified life sciences company Tauriga Sciences’ Tauri-Gum product line this week received approval from the state of Alaska to do business in that state after being granted a Product Endorsement Approval Notice from the Alaska Division of Agriculture (Industrial Hemp Program).

Tauriga manufactures and distributes several proprietary retail products and product lines, mainly focused on the cannabidiol (CBD) and cannabigerol (CBG) edibles market segment. It already sells its Tauri-Gum across several states through a variety of retail outlets, including Walmart, Giant, QuickChek, Circle K and others.

The main Tauri-Gum lineup is made up of a proprietary supplement chewing gum that is kosher certified, halal certified and vegan formulated. The flavor and cannabinoid profiles include CBD Infused Tauri-Gum flavors mint, blood orange and pomegranate; CBG Infused Tauri-Gum flavors peach-lemon and black currant; DELTA 8 THC Infused Tauri-Gum flavor evergreen mint; Vitamin C + Zinc Infused Tauri-Gum flavor pear bellini; Caffeine Infused Tauri-Gum flavor cherry lime rickey; and Vitamin D3 Infused Tauri-Gum flavor golden raspberry.

The company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing e-commerce business segment.

In addition to its retail sales, Tauriga also has an ongoing Pharmaceutical Development initiative, which is developing a proposed pharmaceutical grade version of Tauri-Gum for nausea regulation, specifically designed for chemotherapy patients.

Tauriga is headquartered in Wappingers Falls, N.Y., in the state’s Hudson Valley region and operates full-time e-commerce fulfillment centers in Montgomery, Texas, and Brooklyn, N.Y.

Related Articles Read More >

CBD Skincare Products Market Projected to Grow
HighBridge Premium Brings Production to Texas
Seasonal Peach and Ginger CBD Tincture
Rya Organics Launches Reformulated Sleep Tonic

Stay Up To Date

Need CBD News in a minute? We deliver!
CBD Sign Up
CBD Retail Trends
  • Enews Signup
  • Contact Us
  • CStore Decisions
  • CStore Products
  • National Advisory Group for Convenience Retail

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search CBD Retail Trends

  • CBD Retail Trends
  • Industry News
  • Function
    • Anxiety
    • Excercise
    • Focus
    • Immunity
    • Recovery
    • Sleep
    • Stress
  • Products
    • Beverages
    • Delta-8 THC
    • Edibles
    • Oils & Tinctures
    • Oral Supplements & Tinctures
    • Shots
    • Smoking and Vape
    • Snacks
    • Supplements
    • Topicals
  • Retail Segment
    • Convenience
    • Health & Wellness
    • Medical Dispensary
    • Pets
    • Specialty
  • Commentary
  • FAQs
  • Research
  • Legal & Regulatory
  • Video